InMed Pharmaceuticals Insider Trades
NASDAQ: INMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 3 · $14.48K
- Sales
- 0 · $0
- Shares bought / sold
- 10.90K / 0
- Net activity
- Net buying $14,484
InMed Pharmaceuticals insider activity
Over the last 12 months, InMed Pharmaceuticals insiders reported 3 transactions on SEC Form 4: 3 open-market purchases and 0 sales. Insiders bought $14,484 and sold $0 worth of stock, for net insider buying of $14,484. The most recent filing shows ADAR1 Capital Management, LLC & Schneeberger Daniel (10% Owner) buying 2,256 shares at $1.33 on Oct 8, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put INM's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
INM insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 8, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 2,256 | $3.00K | Form 4 |
| Oct 7, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 3,046 | $4.05K | Form 4 |
| Oct 6, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 5,601 | $7.44K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4